Advanced search
Publication Cover
Hematology Volume 28, 2023 - Issue 1
Submit an article Journal homepage
556
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Industry’s role in HIV, hepatitis B, and hepatitis C exclusion in AML and MDS clinical trials

Tahsin Anwara Augusta University, Augusta, GeorgiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3160-802X
ORCID Icon,
Sean Malhotrab Emory University, Atlanta, Georgia
,
Mohammad A. H. Mianc Augusta University Medical Center, Augusta, Georgia;d Georgia Cancer Center, Augusta University, Augusta, Georgia
,
Tahiya Anwarc Augusta University Medical Center, Augusta, Georgia
,
Vamsi Kotaa Augusta University, Augusta, Georgia;c Augusta University Medical Center, Augusta, Georgia;d Georgia Cancer Center, Augusta University, Augusta, Georgia;e Medical College of Georgia, Augusta University, Augusta, Georgia
&
Mahran Shoukiere Medical College of Georgia, Augusta University, Augusta, Georgia
Article: 2254558 | Published online: 07 Sep 2023

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.